These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17213265)

  • 1. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia.
    Kwon KT; Oh WS; Song JH; Chang HH; Jung SI; Kim SW; Ryu SY; Heo ST; Jung DS; Rhee JY; Shin SY; Ko KS; Peck KR; Lee NY
    J Antimicrob Chemother; 2007 Mar; 59(3):525-30. PubMed ID: 17213265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
    Jamulitrat S; Arunpan P; Phainuphong P
    J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G; Sariguzel F; Sumerkan B
    Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
    Jamulitrat S; Thongpiyapoom S; Suwalak N
    J Med Assoc Thai; 2007 Oct; 90(10):2181-91. PubMed ID: 18041440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risk factors of Acinetobacter baumannii bacteraemia.
    Choi JY; Park YS; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YA; Song YG; Yong D; Lee K; Kim JM
    Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
    Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
    J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
    Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
    J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
    Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
    J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
    Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
    Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
    Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
    Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes.
    Song JS; Choe PG; Song KH; Park WB; Park SW; Kim HB; Oh MD; Kim EC; Kim NJ
    Epidemiol Infect; 2012 Jul; 140(7):1267-76. PubMed ID: 21906414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraintestinal focal infections in adults with nontyphoid Salmonella bacteraemia: predisposing factors and clinical outcome.
    Chen PL; Chang CM; Wu CJ; Ko NY; Lee NY; Lee HC; Shih HI; Lee CC; Wang RR; Ko WC
    J Intern Med; 2007 Jan; 261(1):91-100. PubMed ID: 17222172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
    Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
    Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
    J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.
    Wang YC; Lee YT; Yang YS; Chen CT; Chiu CH; Yin T; Kuo SC; Chen TL; Lin JC; Wang FD; Fung CP; Chang FY
    Clin Microbiol Infect; 2015 Aug; 21(8):758-64. PubMed ID: 25980356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.
    Shih MJ; Lee NY; Lee HC; Chang CM; Wu CJ; Chen PL; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):118-23. PubMed ID: 18473098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.